Skip to main content
Log in

Myasthenia Gravis. Anti-acetylcholine receptor antibodies

  • Original Articles
  • Published:
The Italian Journal of Neurological Sciences Aims and scope Submit manuscript

Abstract

Human acetylcholine receptor and the Lefvert method (13) were used to determine the serum levels of anti-acetylcholine receptor antibodies in 27 patients with Myasthenia Gravis.

Antibodies were detected in 22 patients (81%). Negative results were generally obtained in patients having milder forms of the disease. To find out whether serum levels of antibodies correlate with the severity of the disease, we compared the median antibody levels in patients with Type 1 and 2A Myasthenia Gravis with those of patients with type 2B and 3. Significantly lower titers were observed in the first group. Nevertheless, there were many overlapping values in the range of each class of the disease. A more definite relationship was observed in the follow-up of single patients. As a rule, clinical deterioration was accompanied by an increase of antibody levels and viceversa.

Sommario

Utilizzando recettore acetilcolinico prelevato da muscolo umano, noi abbiamo seguito il metodo di Lefvert [13] per determinare il livello serico degli anticorpi diretti contro il recettore acetilcolinico in 27 pazienti affetti da Miastenia Grave.

Gli anticorpi erano evidenziati in 22 pazienti (81%). Risultati negativi erano generalmente osservati in pazienti affetti dalle forme più lievi della malattia. Per studiare la possibile relazione tra livello serico anticorpale e severità della malattia abbiamo comparato i valori mediani dei titoli anticorpali in pazienti con Miastenia Grave tipo 1 e 2A nei confronti di quelli misurati in pazienti con Miastenia Grave tipo 2B e 3. Titoli significativamente più bassi erano osservati nel primo gruppo. Tuttavia frequenti sovrapposizioni erano osservate nei range di ciascuna classe della malattia. Una più definita relazione era notata nel follow-up di singoli pazienti. Generalmente il deterioramento clinico era accompagnato da un aumento del livello anticorpale, e viceversa.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aharonov A., Abramsky O., Tarrab-Hazdai R., Fuchs S.:Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis. Lancet (2) 7930: 340-342, 1975.

    CAS  PubMed  Google Scholar 

  2. Almon R.R., Andrew C.G., Appel S.H.:Serum globulin in myasthenia gravis: Inhibition of alpha Bungarotoxin binding to Acetylcholine receptors. Science 186: 55–57, 1974.

    CAS  PubMed  Google Scholar 

  3. Almon R.R., Appel S.H.:Interaction of myasthenic serum globulin with the acetylcholine receptor. Biochem. Biophys. Acta 393: 66–77, 1975.

    CAS  PubMed  Google Scholar 

  4. Appel S.H., Almon R.R., Levy N.:Acetylcholine receptor antibodies in myashenia gravis. N. Engl. J. Med. 293 (15): 760–761, 1975.

    CAS  PubMed  Google Scholar 

  5. De Crousaz G., Fulpius B., Monnier V., Regli F.:Dosage des anticorps dirigés contre le récepteur nicotinique de l'acetylcholine: corrélations clinicoimmunologiques chez 30 myasthéniques. Schweiz. Med. Wschr. 108: 602–607, 1978.

    PubMed  Google Scholar 

  6. Drachman D.B., Angus W.C., Adams R.N., Michelson J.D., Hoffman G.J.:Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation. N. Engl. J. Med. 298: 1116–1122, 1978.

    CAS  PubMed  Google Scholar 

  7. Drachman D.B., Adams R.N., Stanley E.F., Pestron K.A.:Mechanism of acetylcholine receptor loss in myasthenia gravis. J. Neurol. Neurosurg. Psychiat. 43: 601–610, 1980.

    CAS  PubMed  Google Scholar 

  8. Fambrough D.M., Drachman D.B., Satyamuati S.:Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors. Science 182: 293–295, 1973.

    CAS  PubMed  Google Scholar 

  9. Heilbronn E., Lefvert A.K., Stalberg E.:Acetylcholine receptor antibodies in the diagnosis of human and experimental myasthenia gravis: Muscle & Nerve 1: 427–431, 1978.

    Article  CAS  Google Scholar 

  10. Heilbronn E., Stalberg E.:The pathogenesis of myasthenia gravis. J. Neurochem. 31: 5–11, 1978.

    CAS  PubMed  Google Scholar 

  11. Hunter W.M., Greenwood F.C.:Preparation of iodine 131 I labelled growth hormone of high specific activity. Nature (London) 194: 495–496, 1962.

    CAS  Google Scholar 

  12. Lefvert A.K., Mattel G.:Antibodies against human cholinergic receptor proteins in patients with Myasthenia Gravis: studies during immunosuppressive treatment. Acta Med. Scand. 201: 181–182, 1977.

    CAS  PubMed  Google Scholar 

  13. Lefvert A.K., Bergstrom K., Mattel G., Osterman P.O., Pirskanen R.:Determination of acetylcholine receptor antibodies in myasthenia gravis: clinical usefulness and pathogenic implications. J. Neurol. Neurosurg. Psychiat. 41: 394–401, 1978.

    CAS  PubMed  Google Scholar 

  14. Lindstrom J.M., Lennon V., Seybold M.E., Whittingham S.:Experimental autoimmune myasthenia gravis and myasthenia gravis: biochemical and immunochemical aspects. Ann. NY Acad. Sci. 274: 254–274, 1976.

    CAS  PubMed  Google Scholar 

  15. Lindstrom J.M., Seybold M.E., Lennon V.A., Wittingham S., Duane D.:Antibody to acetylcholine receptor in myasthenia gravis. Neurology 26: 1054–1059, 1976.

    CAS  PubMed  Google Scholar 

  16. Lindstrom J.M.:Immunological studies of acetylcholine receptors. J. Supramol. Struct. 4: 384–403, 1976.

    Article  Google Scholar 

  17. Lindstrom J.:An assay for antibodies to human acetylcholine receptor in serum from patients with Myasthenia Gravis. Clin. Immunol. Immunopathol. 7: 36–43, 1977.

    Article  CAS  PubMed  Google Scholar 

  18. Lindstrom J., Campbell M., Nave B.:Specificities of antibodies to acetylcholine receptors. Muscle & Nerve 1: 140–145, 1978.

    Article  CAS  Google Scholar 

  19. Mittag T., Kornfeld P., Tormay A. Wco C.:Detection of anti-acetylcholine receptors factors in serum and thymus from patients with myasthenia gravis. N. Engl. J. Med. 294: 691–694, 1976.

    CAS  PubMed  Google Scholar 

  20. Monnier V.M., Fulpius B.W.:A radioimmunoassay for the quantitative evaluation of anti-human acetylcholine receptor antibodies in myasthenia gravis. Clin. Exp. Immunol. 29: 16–22, 1977.

    CAS  PubMed  Google Scholar 

  21. Newson-Davis J., Pinching A.J., Vincent A., Wilson S.G.:Function of circulating antibody to acetylcholine receptor in Myasthenia Gravis: investigation by plasma-exchange. Neurology 28: 266–272, 1978.

    Google Scholar 

  22. Osserman K.E., Genkins G.:Studies in Myasthenia Gravis: review of a twenty years experience in over 1.200 patients. Mount Sinai J. Med. 38: 497–537, 1971.

    CAS  Google Scholar 

  23. Roitt I.:Autoimmunity. p. 265 in Essential Immunology Blackwell Scientific Publ. Oxford, 1977.

    Google Scholar 

  24. Savage-Marengo T., Harrison R., Lunt G.G., Behan P.O.:Patient-specific anti-receptor antibody patterns in myasthenia gravis. J. Neurol. Neurosurg. Psychiat. 43 (4): 316–320, 1980.

    CAS  PubMed  Google Scholar 

  25. Vincent A., Newsom-Davis J.:Anti-acetylcholine receptor antibodies. J. Neurol. Neurosurg. Psychiat. 43: 590–600, 1980.

    CAS  PubMed  Google Scholar 

  26. Zurn A., Fulpius B.W.:Studies of 2 different subpopulations of antiacetylcholine receptor antibodies in a rabbit with experimental autoimmune myasthenia gravis. Eur. J. Immunol. 7: 529–532, 1977.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cerrato, D., Ariano, C., La Mantia, L. et al. Myasthenia Gravis. Anti-acetylcholine receptor antibodies. Ital J Neuro Sci 2, 165–171 (1981). https://doi.org/10.1007/BF02335439

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02335439

Key-Words

Navigation